We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Biochemical Markers Used in Diagnosis of Nasopharyngeal Cancer

By LabMedica International staff writers
Posted on 30 Mar 2011
Metabolic profiling of patients with nasopharyngeal carcinoma (NPC) revealed that four chemical in their sera were useful as diagnostic markers.

Serum metabolite levels can be ascertained by using both liquid and gas chromatography with mass spectrometry techniques (LC/GC-MS) and followed in the blood sera of patients suffering from carcinoma before, during, and after therapy.

In a study performed at Jinan University, (Zhuhai, China), scientists evaluated 51 serum metabolites in 49 NPC patients, 37 throat cancer patients and 40 healthy controls. More...
Nasopharyngeal biopsy tissues were collected from 31 patients with NPC and 27 healthy people who were pathologically diagnosed as nonnasopharyngeal carcinoma. High metabolites were selected and confirmed in NPC tissues. Sensitivity and specificity were appraised for 53 NPC diagnoses.

The LC/GC–MS profiles were significantly different among the three groups. In these profiles, 51 metabolites were considered endogenous metabolites, which included organic acids, amino acids, and fatty acids involved in multiple biochemical processes. These were studied further for their potential to represent the metabolic pattern of the disease and recovery states.

The results showed that four metabolites, kynurenine, N-acetylglucosaminylamine, N-acetylglucosamine and hydroxyphenylpyruvate gradually increased from normal nasopharyngeal, atypical hyperplasia to NPC. Their sensitivity and specificity of the four metabolites were respectively 79% and 71%, 78% and 69%, 83% and 68%, 84% and 73% for NPC diagnosis. Three other metabolites, stearic acid, N-acetylgalactosamine and glycine did not change. This implies that these four metabolites may serve as potential markers as after radiotherapy, the four metabolites decreased gradually, tended to a normal level, and were associated with rate of tumor reduction.

The authors concluded that the four metabolites, hydroxyphenylpyruvate, N-acetylglucosaminylamine, N-acetylglucosamine, and kynurenine, could potentially serve as biomarkers for the early diagnosis and efficacy of therapy, and could also be used to monitor the recurrence and metastasis of NPC. The study was published online on March 12, 2011, in Clinical Biochemistry.

Related Links:

Jinan University



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.